US2016251405A1PendingUtilityA1

Application of metrnl protein in preparing hypolipidemic, hypoglycemic medicine

39
Assignee: MIAO CHAOYUPriority: Oct 29, 2013Filed: Apr 25, 2016Published: Sep 1, 2016
Est. expiryOct 29, 2033(~7.3 yrs left)· nominal 20-yr term from priority
Inventors:Chaoyu MiaoZhiyong LiPei Wang
A61K 38/19C07K 14/52A23V 2002/00A61P 3/10A61P 3/06A61K 38/22A61K 39/00C07K 14/475A23L 1/305A23L 33/17
39
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides an application of Metrnl protein in preparing a hypolipidemic, hypoglycemic medicine or dietary supplement. The present invention further provides a method for preparing a mouse with fat-specific overexpression of Metrnl.

Claims

exact text as granted — not AI-modified
1 . Application of Metrnl protein in preparing hypoglycemic medicine or dietary supplement. 
     
     
         2 . The application according to  claim 1 , wherein said application means to reduce blood glucose levels of individuals with hyperlipemia. 
     
     
         3 . Application of Metrnl protein in preparing hypolipidemic medicine or dietary supplement.

Join the waitlist — get patent alerts

Track US2016251405A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.